摘要
I would not go so far as to consider desmoglein autoantibodies as only ‘witnesses of disease’. An important role for pemphigus vulgaris IgG (PVIgG) in pemphigus pathogenesis cannot be denied. Indeed, PVIgG is pathogenic in passive transfer studies (1) and recognizes the desmosomal cadherin desmoglein (2). However, it must be pointed out that anti-desmoglein IgG is not alone, as other targets of autoantibodies in pemphigus, including acetylcholine receptors and pemphaxin, have been described (3, 4). Moreover, wherever the autoantibodies bind, the mechanism of blister induction by pemphigus antibodies remains to be fully elucidated. Acantholysis as a result of both signal transduction events initiated by the binding of autoantibodies and the direct effect on desmosomal cadherins by steric hindrance are partially supported by experimental evidences (5). However, one continues to suspect that these processes do not account for the entire story. This bias is further supported by the fact that cell–cell contacts form even in the presence of PVIgG (6) and, most of all, by the old ultrastructural observation of epidermal keratinocytes being destroyed by PVIgG (7). While it is difficult to establish whether those keratinocytes were actually killed via apoptosis, the involvement of cell death in pemphigus could be envisaged. Indeed, pemphigus is a disease due to the lack of cell adhesion (8) and apoptosis can occur in association with cell detachment (9). These concepts are fully confirmed by the detection of apoptosis in lesional pemphigus skin. In particular, acantholytic cells express the major markers of apoptosis (10). More interestingly, positive Tdt-mediated UTP nick-end labelling (TUNEL) nuclei are also found attached to the blister roof, suggesting the presence of apoptotic cells in perilesional skin before detachment. Indeed, perilesional pemphigus skin is characterized by a high number of TUNEL-positive cells (11), while apoptotic cells expressing Ig and activated caspase-8 are detected at the edge of the lesion, in areas where no disruption of cell–cell contacts is visible (10). These data definitely demonstrate that, in pemphigus, apoptosis takes place in keratinocytes before acantholysis. If cells first die then detach, what is the pathway inducing keratinocyte apoptosis in pemphigus? This question is well addressed by the data that two independent groups have recently published. Wang et al. (10) report that acantholysis-like lesions are observed in cultured keratinocytes treated with both PVIgG and anti-FasR, while PVIgG induces the clustering of FAS receptor (FasR), Fas ligand (FasL) and caspase-8 on the cell membrane several hours before the formation of the lesions. Similarly, Puviani et al. demonstrate that sera from pemphigus patients express very high levels of FasL, which become undetectable upon corticosteroid treatment. Moreover, untreated PV patient sera induce apoptosis and the activation of caspase-8 in cultured keratinocytes, and this is partially inhibited by anti-FasL neutralizing antibody and by caspase-8 inhibitors, respectively (11). Taken together, these data indicate that FasL and the extrinsic apoptotic pathway play a critical role in the mechanisms underlying acantholysis. Whatever the nature of the pemphigus autoantibodies, exposure to PVIgG upregulates the expression of several pro-apoptotic genes, including FasL many hours before acantholysis actually occurs (12). Finally, it is interesting to note that caspase-3 directly cleaves desmoglein 3 and other desmosomal proteins, thereby causing desmosome disruption after the induction of apoptosis (13). In conclusion, if the ‘Pemphigus story’ were a movie, desmoglein autoantibodies would most likely still play the leading role, while FasL would play the role of a supporting actor. However, as we know quite well, sometimes, supporting roles overshadow the main actor. In fact, this year, we vote for FasL to win the Oscar as the ‘Best Actor in a Supporting Role’ for the exciting movie ‘Pemphigus story’.